[1]
Rzoqy, H.A. et al. 2026. The Utility of Serum CD152 Concentration as a Differential Biomarker in Hashimoto’s Thyroiditis. International Journal of Medical Science and Dental Health. 12, 04 (Apr. 2026), 26–31. DOI:https://doi.org/10.55640/ijmsdh-12-04-05.